These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18264030)

  • 1. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies.
    Christensen DD
    CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
    Golden R
    Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Art and the brain: a view from dementia.
    Gretton C; ffytche DH
    Int J Geriatr Psychiatry; 2014 Feb; 29(2):111-26. PubMed ID: 23925829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?
    Dal Prà I; Chiarini A; Gui L; Chakravarthy B; Pacchiana R; Gardenal E; Whitfield JF; Armato U
    Neuroscientist; 2015 Feb; 21(1):9-29. PubMed ID: 24740577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
    Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
    Ising C; Stanley M; Holtzman DM
    Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-controlled study of altered visual art production in Alzheimer's and FTLD.
    Rankin KP; Liu AA; Howard S; Slama H; Hou CE; Shuster K; Miller BL
    Cogn Behav Neurol; 2007 Mar; 20(1):48-61. PubMed ID: 17356345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta pathology in Alzheimer's disease and schizophrenia.
    Religa D; Laudon H; Styczynska M; Winblad B; Näslund J; Haroutunian V
    Am J Psychiatry; 2003 May; 160(5):867-72. PubMed ID: 12727689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging treatments for Alzheimer's disease.
    Corbett A; Ballard C
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on pharmacotherapy of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Artistic creativity and dementia].
    Sellal F; Musacchio M
    Psychol Neuropsychiatr Vieil; 2008 Mar; 6(1):57-66. PubMed ID: 18364297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
    van Reekum R; Simard M; Farcnik K
    Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategies for the prevention of dementia from Alzheimer's disease.
    Shineman DW; Fillit HM
    Dialogues Clin Neurosci; 2009; 11(2):129-34. PubMed ID: 19585948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42.
    Iijima K; Iijima-Ando K
    J Alzheimers Dis; 2008 Dec; 15(4):523-40. PubMed ID: 19096154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.